Company Provides Guidance for 2011 SAN DIEGO – Illumina, Inc. (NASDAQ:ILMN) today announced preliminary revenue for the fourth quarter of 2010 of approximately $260 million. This implies fiscal year 2010 revenue of approximately $901 million or annual growth of 35%. The company also announced preliminary non-GAAP earnings per share for the fourth quarter and fiscal […]

Strasbourg, France – Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, announces the completion of a funding round in which it raised EUR 2.5 million. This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which […]

Strasbourg, France – Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, announces the completion of a funding round in which it raised EUR 2.5 million. This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which […]

PALO ALTO, Calif. – StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell ten million shares of its common stock to selected institutional investors at a price of $1.00 per share, which represents a 10% discount to the closing price per share of January 6. The offering is expected to […]

Center Awards $23.9 million to foster job growth in the Massachusetts Life Sciences sectors Waltham, MA – The Massachusetts Life Sciences Center announced today that the Center’s Board of Directors has awarded $23.9 million in tax incentives to 30 life sciences companies. The recipient companies have committed to creating nearly 1,000 new jobs in the […]

RESEARCH TRIANGLE PARK, North Carolina – Precision BioSciences, Inc., today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and […]

Goal Is Highly Scalable Pharmacogenomics Research MOUNTAIN VIEW, CA – 23andMe has launched a project funded by the National Institutes of Health (NIH) which is aimed at validating 23andMe’s highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for “Web-based Phenotyping for Genome-Wide […]

Fremont, Calif. – WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that its Malaysian subsidiary, WaferGen Biosystems (M) Sdn. Bhd., has signed a purchase agreement with an investor for a $5 million private placement of the Malaysian subsidiary’s Series C-1 redeemable convertible preference shares. WaferGen also announced that it […]